Skip to main content
Top
Published in: Journal of Translational Medicine 1/2014

Open Access 01-12-2014 | Research

Quantification of tumour budding, lymphatic vessel density and invasion through image analysis in colorectal cancer

Authors: Peter D Caie, Arran K Turnbull, Susan M Farrington, Anca Oniscu, David J Harrison

Published in: Journal of Translational Medicine | Issue 1/2014

Login to get access

Abstract

Background

Tumour budding (TB), lymphatic vessel density (LVD) and lymphatic vessel invasion (LVI) have shown promise as prognostic factors in colorectal cancer (CRC) but reproducibility using conventional histopathology is challenging. We demonstrate image analysis methodology to quantify the histopathological features which could permit standardisation across institutes and aid risk stratification of Dukes B patients.

Methods

Multiplexed immunofluorescence of pan-cytokeratin, D2-40 and DAPI identified epithelium, lymphatic vessels and all nuclei respectively in tissue sections from 50 patients diagnosed with Dukes A (n = 13), Dukes B (n = 29) and Dukes C (n = 8) CRC. An image analysis algorithm was developed and performed, on digitised images of the CRC tissue sections, to quantify TB, LVD, and LVI at the invasive front.

Results

TB (HR =5.7; 95% CI, 2.38-13.8), LVD (HR =5.1; 95% CI, 2.04-12.99) and LVI (HR =9.9; 95% CI, 3.57-27.98) were successfully quantified through image analysis and all were shown to be significantly associated with poor survival, in univariate analyses. LVI (HR =6.08; 95% CI, 1.17-31.41) is an independent prognostic factor within the study and was correlated to both TB (Pearson r =0.71, p <0.0003) and LVD (Pearson r =0.69, p <0.0003).

Conclusion

We demonstrate methodology through image analysis which can standardise the quantification of TB, LVD and LVI from a single tissue section while decreasing observer variability. We suggest this technology is capable of stratifying a high risk Dukes B CRC subpopulation and we show the three histopathological features to be of prognostic significance.
Appendix
Available only for authorised users
Literature
2.
go back to reference Lan YT, Yang SH, Chang SC, Liang WY, Li AF, Wang HS, Jiang JK, Chen WS, Lin TC, Lin JK: Analysis of the seventh edition of American Joint Committee on colon cancer staging. Int J Colorectal Dis. 2012, 27: 657-663.CrossRefPubMed Lan YT, Yang SH, Chang SC, Liang WY, Li AF, Wang HS, Jiang JK, Chen WS, Lin TC, Lin JK: Analysis of the seventh edition of American Joint Committee on colon cancer staging. Int J Colorectal Dis. 2012, 27: 657-663.CrossRefPubMed
3.
go back to reference Poston GJ, Tait D, O'Connell S, Bennett A, Berendse S: Diagnosis and management of colorectal cancer: summary of NICE guidance. BMJ. 2011, 343: d6751-CrossRefPubMed Poston GJ, Tait D, O'Connell S, Bennett A, Berendse S: Diagnosis and management of colorectal cancer: summary of NICE guidance. BMJ. 2011, 343: d6751-CrossRefPubMed
4.
go back to reference O'Connell JB, Maggard MA, Ko CY: Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst. 2004, 96: 1420-1425.CrossRefPubMed O'Connell JB, Maggard MA, Ko CY: Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst. 2004, 96: 1420-1425.CrossRefPubMed
5.
go back to reference Huh JW, Lee JH, Kim HR, Kim YJ: Prognostic significance of lymphovascular or perineural invasion in patients with locally advanced colorectal cancer. Am J Surg. 2013, 206: 758-763.CrossRefPubMed Huh JW, Lee JH, Kim HR, Kim YJ: Prognostic significance of lymphovascular or perineural invasion in patients with locally advanced colorectal cancer. Am J Surg. 2013, 206: 758-763.CrossRefPubMed
6.
go back to reference Chang S-C, Lin C-C, Wang H-S, Yang S-H, Jiang J-K, Lan Y-T, Lin T-C, Li AF-Y, Chen W-S, Lin J-K: Lymphovascular invasion determines the outcome of stage I colorectal cancer patients. Formosan J Surgery. 2012, 45: 141-145.CrossRef Chang S-C, Lin C-C, Wang H-S, Yang S-H, Jiang J-K, Lan Y-T, Lin T-C, Li AF-Y, Chen W-S, Lin J-K: Lymphovascular invasion determines the outcome of stage I colorectal cancer patients. Formosan J Surgery. 2012, 45: 141-145.CrossRef
7.
go back to reference Betge J, Pollheimer MJ, Lindtner RA, Kornprat P, Schlemmer A, Rehak P, Vieth M, Hoefler G, Langner C: Intramural and extramural vascular invasion in colorectal cancer: prognostic significance and quality of pathology reporting. Cancer. 2012, 118: 628-638.CrossRefPubMed Betge J, Pollheimer MJ, Lindtner RA, Kornprat P, Schlemmer A, Rehak P, Vieth M, Hoefler G, Langner C: Intramural and extramural vascular invasion in colorectal cancer: prognostic significance and quality of pathology reporting. Cancer. 2012, 118: 628-638.CrossRefPubMed
8.
go back to reference Barresi V, Reggiani-Bonetti L, Di Gregorio C, De Leon MP, Barresi G: Lymphatic vessel density and its prognostic value in stage I colorectal carcinoma. J Clin Pathol. 2011, 64: 6-12.CrossRefPubMed Barresi V, Reggiani-Bonetti L, Di Gregorio C, De Leon MP, Barresi G: Lymphatic vessel density and its prognostic value in stage I colorectal carcinoma. J Clin Pathol. 2011, 64: 6-12.CrossRefPubMed
9.
go back to reference Cacchi C, Arnholdt HM, Jahnig H, Anthuber M, Probst A, Oruzio DV, Markl B: Clinical significance of lymph vessel density in T3 colorectal carcinoma. Int J Colorectal Dis. 2012, 27: 721-726.CrossRefPubMed Cacchi C, Arnholdt HM, Jahnig H, Anthuber M, Probst A, Oruzio DV, Markl B: Clinical significance of lymph vessel density in T3 colorectal carcinoma. Int J Colorectal Dis. 2012, 27: 721-726.CrossRefPubMed
10.
go back to reference Royston D, Jackson DG: Mechanisms of lymphatic metastasis in human colorectal adenocarcinoma. J Pathol. 2009, 217: 608-619.CrossRefPubMed Royston D, Jackson DG: Mechanisms of lymphatic metastasis in human colorectal adenocarcinoma. J Pathol. 2009, 217: 608-619.CrossRefPubMed
11.
go back to reference Betge J, Kornprat P, Pollheimer MJ, Lindtner RA, Schlemmer A, Rehak P, Vieth M, Langner C: Tumour budding is an independent predictor of outcome in AJCC/UICC stage II colorectal cancer. Ann Surg Oncol. 2012, 19: 3706-3712.CrossRefPubMed Betge J, Kornprat P, Pollheimer MJ, Lindtner RA, Schlemmer A, Rehak P, Vieth M, Langner C: Tumour budding is an independent predictor of outcome in AJCC/UICC stage II colorectal cancer. Ann Surg Oncol. 2012, 19: 3706-3712.CrossRefPubMed
12.
go back to reference Karamitopoulou E, Zlobec I, Kolzer V, Kondi-Pafiti A, Patsouris ES, Gennatas K, Lugli A: Proposal for a 10-high-power-fields scoring method for the assessment of tumour budding in colorectal cancer. Mod Pathol. 2013, 26: 295-301.CrossRefPubMed Karamitopoulou E, Zlobec I, Kolzer V, Kondi-Pafiti A, Patsouris ES, Gennatas K, Lugli A: Proposal for a 10-high-power-fields scoring method for the assessment of tumour budding in colorectal cancer. Mod Pathol. 2013, 26: 295-301.CrossRefPubMed
13.
go back to reference Ueno H, Murphy J, Jass JR, Mochizuki H, Talbot IC: Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology. 2002, 40: 127-132.CrossRefPubMed Ueno H, Murphy J, Jass JR, Mochizuki H, Talbot IC: Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology. 2002, 40: 127-132.CrossRefPubMed
14.
go back to reference Mitrovic B, Schaeffer DF, Riddell RH, Kirsch R: Tumour budding in colorectal carcinoma: time to take notice. Mod Pathol. 2012, 25: 1315-1325.CrossRefPubMed Mitrovic B, Schaeffer DF, Riddell RH, Kirsch R: Tumour budding in colorectal carcinoma: time to take notice. Mod Pathol. 2012, 25: 1315-1325.CrossRefPubMed
16.
go back to reference Mou S, Soetikno R, Shimoda T, Rouse R, Kaltenbach T: Pathologic predictive factors for lymph node metastasis in submucosal invasive (T1) colorectal cancer: a systematic review and meta-analysis. Surg Endosc. 2013, 27: 2692-2703.CrossRefPubMed Mou S, Soetikno R, Shimoda T, Rouse R, Kaltenbach T: Pathologic predictive factors for lymph node metastasis in submucosal invasive (T1) colorectal cancer: a systematic review and meta-analysis. Surg Endosc. 2013, 27: 2692-2703.CrossRefPubMed
17.
go back to reference Glasgow SC, Bleier JI, Burgart LJ, Finne CO, Lowry AC: Meta-analysis of histopathological features of primary colorectal cancers that predict lymph node metastases. J Gastrointest Surg. 2012, 16: 1019-1028.CrossRefPubMed Glasgow SC, Bleier JI, Burgart LJ, Finne CO, Lowry AC: Meta-analysis of histopathological features of primary colorectal cancers that predict lymph node metastases. J Gastrointest Surg. 2012, 16: 1019-1028.CrossRefPubMed
18.
go back to reference Uribarrena AR, Ortego J, Fuentes J, Raventos N, Parra P, Uribarrena ER: Prognostic value of microvascular density in dukes a and B (t1-t4, n0, m0) colorectal carcinomas. Gastroenterol Res Pract. 2009, 2009: 679830-CrossRef Uribarrena AR, Ortego J, Fuentes J, Raventos N, Parra P, Uribarrena ER: Prognostic value of microvascular density in dukes a and B (t1-t4, n0, m0) colorectal carcinomas. Gastroenterol Res Pract. 2009, 2009: 679830-CrossRef
19.
go back to reference Suzuki A, Togashi K, Nokubi M, Koinuma K, Miyakura Y, Horie H, Lefor AT, Yasuda Y: Evaluation of venous invasion by Elastica van Gieson stain and tumour budding predicts local and distant metastases in patients with T1 stage colorectal cancer. Am J Surg Pathol. 2009, 33: 1601-1607.CrossRefPubMed Suzuki A, Togashi K, Nokubi M, Koinuma K, Miyakura Y, Horie H, Lefor AT, Yasuda Y: Evaluation of venous invasion by Elastica van Gieson stain and tumour budding predicts local and distant metastases in patients with T1 stage colorectal cancer. Am J Surg Pathol. 2009, 33: 1601-1607.CrossRefPubMed
20.
go back to reference Doyle B, Hagan S, Al-Mulla F, Scott L, Harden S, Paul J, Mulcahy H, Murray GI, Sheahan K, O'Sullivan J, Kolch W: Raf kinase inhibitor protein expression combined with peritoneal involvement and lymphovascular invasion predicts prognosis in Dukes' B colorectal cancer patients. Histopathology. 2013, 62: 505-510.CrossRefPubMed Doyle B, Hagan S, Al-Mulla F, Scott L, Harden S, Paul J, Mulcahy H, Murray GI, Sheahan K, O'Sullivan J, Kolch W: Raf kinase inhibitor protein expression combined with peritoneal involvement and lymphovascular invasion predicts prognosis in Dukes' B colorectal cancer patients. Histopathology. 2013, 62: 505-510.CrossRefPubMed
21.
go back to reference Betge J, Kornprat P, Pollheimer MJ, Lindtner RA, Schlemmer A, Rehak P, Vieth M, Langner C: Tumour Budding is an Independent Predictor of Outcome in AJCC/UICC Stage II Colorectal Cancer. Ann Surg Oncol. 2012, 19: 3706-3712.CrossRefPubMed Betge J, Kornprat P, Pollheimer MJ, Lindtner RA, Schlemmer A, Rehak P, Vieth M, Langner C: Tumour Budding is an Independent Predictor of Outcome in AJCC/UICC Stage II Colorectal Cancer. Ann Surg Oncol. 2012, 19: 3706-3712.CrossRefPubMed
22.
go back to reference Barresi V, Reggiani Bonetti L, Vitarelli E, Di Gregorio C, Ponz De Leon M, Barresi G: Immunohistochemical assessment of lymphovascular invasion in stage I colorectal carcinoma: prognostic relevance and correlation with nodal micrometastases. Am J Surg Pathol. 2012, 36: 66-72.CrossRefPubMed Barresi V, Reggiani Bonetti L, Vitarelli E, Di Gregorio C, Ponz De Leon M, Barresi G: Immunohistochemical assessment of lymphovascular invasion in stage I colorectal carcinoma: prognostic relevance and correlation with nodal micrometastases. Am J Surg Pathol. 2012, 36: 66-72.CrossRefPubMed
23.
go back to reference Puppa G, Senore C, Sheahan K, Vieth M, Lugli A, Zlobec I, Pecori S, Wang LM, Langner C, Mitomi H, Nakamura T, Watanabe M, Ueno H, Chasle J, Conley SA, Herlin P, Lauwers GY, Risio M: Diagnostic reproducibility of tumour budding in colorectal cancer: a multicentre, multinational study using virtual microscopy. Histopathology. 2012, 61: 562-575.PubMed Puppa G, Senore C, Sheahan K, Vieth M, Lugli A, Zlobec I, Pecori S, Wang LM, Langner C, Mitomi H, Nakamura T, Watanabe M, Ueno H, Chasle J, Conley SA, Herlin P, Lauwers GY, Risio M: Diagnostic reproducibility of tumour budding in colorectal cancer: a multicentre, multinational study using virtual microscopy. Histopathology. 2012, 61: 562-575.PubMed
24.
go back to reference Horcic M, Koelzer VH, Karamitopoulou E, Terracciano L, Puppa G, Zlobec I, Lugli A: Tumour budding score based on 10 high-power fields is a promising basis for a standardised prognostic scoring system in stage II colorectal cancer. Hum Pathol. 2013, 44: 697-705.CrossRefPubMed Horcic M, Koelzer VH, Karamitopoulou E, Terracciano L, Puppa G, Zlobec I, Lugli A: Tumour budding score based on 10 high-power fields is a promising basis for a standardised prognostic scoring system in stage II colorectal cancer. Hum Pathol. 2013, 44: 697-705.CrossRefPubMed
26.
go back to reference Roxburgh CS, McMillan DC, Anderson JH, McKee RF, Horgan PG, Foulis AK: Elastica staining for venous invasion results in superior prediction of cancer-specific survival in colorectal cancer. Ann Surg. 2010, 252: 989-997.CrossRefPubMed Roxburgh CS, McMillan DC, Anderson JH, McKee RF, Horgan PG, Foulis AK: Elastica staining for venous invasion results in superior prediction of cancer-specific survival in colorectal cancer. Ann Surg. 2010, 252: 989-997.CrossRefPubMed
27.
go back to reference Kingston EF, Goulding H, Bateman AC: Vascular invasion is underrecognized in colorectal cancer using conventional hematoxylin and eosin staining. Dis Colon Rectum. 2007, 50: 1867-1872.CrossRefPubMed Kingston EF, Goulding H, Bateman AC: Vascular invasion is underrecognized in colorectal cancer using conventional hematoxylin and eosin staining. Dis Colon Rectum. 2007, 50: 1867-1872.CrossRefPubMed
28.
go back to reference Ohtsuki K, Koyama F, Tamura T, Enomoto Y, Fujii H, Mukogawa T, Nakagawa T, Uchimoto K, Nakamura S, Nonomura A, Nakajima Y: Prognostic value of immunohistochemical analysis of tumour budding in colorectal carcinoma. Anticancer Res. 2008, 28: 1831-1836.PubMed Ohtsuki K, Koyama F, Tamura T, Enomoto Y, Fujii H, Mukogawa T, Nakagawa T, Uchimoto K, Nakamura S, Nonomura A, Nakajima Y: Prognostic value of immunohistochemical analysis of tumour budding in colorectal carcinoma. Anticancer Res. 2008, 28: 1831-1836.PubMed
29.
go back to reference Lin M, Ma SP, Lin HZ, Ji P, Xie D, Yu JX: Intratumoural as well as peritumoural lymphatic vessel invasion correlates with lymph node metastasis and unfavourable outcome in colorectal cancer. Clin Exp Metastasis. 2010, 27: 123-132.CrossRefPubMed Lin M, Ma SP, Lin HZ, Ji P, Xie D, Yu JX: Intratumoural as well as peritumoural lymphatic vessel invasion correlates with lymph node metastasis and unfavourable outcome in colorectal cancer. Clin Exp Metastasis. 2010, 27: 123-132.CrossRefPubMed
30.
go back to reference Kazama S, Watanabe T, Ajioka Y, Kanazawa T, Nagawa H: Tumour budding at the deepest invasive margin correlates with lymph node metastasis in submucosal colorectal cancer detected by anticytokeratin antibody CAM5.2. Br J Cancer. 2006, 94: 293-298.PubMedCentralCrossRefPubMed Kazama S, Watanabe T, Ajioka Y, Kanazawa T, Nagawa H: Tumour budding at the deepest invasive margin correlates with lymph node metastasis in submucosal colorectal cancer detected by anticytokeratin antibody CAM5.2. Br J Cancer. 2006, 94: 293-298.PubMedCentralCrossRefPubMed
31.
go back to reference Tetu B, Evans A: Canadian Licensure for the Use of Digital Pathology for Routine Diagnoses. Arch Pathol Lab Med. 2013, 138: 302-304.CrossRefPubMed Tetu B, Evans A: Canadian Licensure for the Use of Digital Pathology for Routine Diagnoses. Arch Pathol Lab Med. 2013, 138: 302-304.CrossRefPubMed
32.
go back to reference Pages F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R, Mlecnik B, Kirilovsky A, Nilsson M, Damotte D, Meatchi T, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Galon J: Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med. 2005, 353: 2654-2666.CrossRefPubMed Pages F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R, Mlecnik B, Kirilovsky A, Nilsson M, Damotte D, Meatchi T, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Galon J: Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med. 2005, 353: 2654-2666.CrossRefPubMed
33.
go back to reference Angell HK, Gray N, Womack C, Pritchard DI, Wilkinson RW, Cumberbatch M: Digital pattern recognition-based image analysis quantifies immune infiltrates in distinct tissue regions of colorectal cancer and identifies a metastatic phenotype. Br J Cancer. 2013, 109: 1618-1624.PubMedCentralCrossRefPubMed Angell HK, Gray N, Womack C, Pritchard DI, Wilkinson RW, Cumberbatch M: Digital pattern recognition-based image analysis quantifies immune infiltrates in distinct tissue regions of colorectal cancer and identifies a metastatic phenotype. Br J Cancer. 2013, 109: 1618-1624.PubMedCentralCrossRefPubMed
34.
go back to reference Hase K, Shatney C, Johnson D, Trollope M, Vierra M: Prognostic value of tumour "budding" in patients with colorectal cancer. Dis Colon Rectum. 1993, 36: 627-635.CrossRefPubMed Hase K, Shatney C, Johnson D, Trollope M, Vierra M: Prognostic value of tumour "budding" in patients with colorectal cancer. Dis Colon Rectum. 1993, 36: 627-635.CrossRefPubMed
35.
go back to reference Camp RL, Dolled-Filhart M, Rimm DL: X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004, 10: 7252-7259.CrossRefPubMed Camp RL, Dolled-Filhart M, Rimm DL: X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004, 10: 7252-7259.CrossRefPubMed
36.
go back to reference Lubbock AL, Katz E, Harrison DJ, Overton IM: TMA Navigator: Network inference, patient stratification and survival analysis with tissue microarray data. Nucleic Acids Res. 2013, 41: W562-W568.PubMedCentralCrossRefPubMed Lubbock AL, Katz E, Harrison DJ, Overton IM: TMA Navigator: Network inference, patient stratification and survival analysis with tissue microarray data. Nucleic Acids Res. 2013, 41: W562-W568.PubMedCentralCrossRefPubMed
37.
go back to reference Midgley R, Kerr DJ: Adjuvant chemotherapy for stage II colorectal cancer: the time is right!. Nat Clin Pract Oncol. 2005, 2: 364-369.CrossRefPubMed Midgley R, Kerr DJ: Adjuvant chemotherapy for stage II colorectal cancer: the time is right!. Nat Clin Pract Oncol. 2005, 2: 364-369.CrossRefPubMed
38.
go back to reference Wang TB, Chen ZG, Wei XQ, Wei B, Dong WG: Serum vascular endothelial growth factor-C and lymphoangiogenesis are associated with the lymph node metastasis and prognosis of patients with colorectal cancer. ANZ J Surg. 2011, 81: 694-699.CrossRefPubMed Wang TB, Chen ZG, Wei XQ, Wei B, Dong WG: Serum vascular endothelial growth factor-C and lymphoangiogenesis are associated with the lymph node metastasis and prognosis of patients with colorectal cancer. ANZ J Surg. 2011, 81: 694-699.CrossRefPubMed
39.
go back to reference Gao J, Knutsen A, Arbman G, Carstensen J, Franlund B, Sun XF: Clinical and biological significance of angiogenesis and lymphangiogenesis in colorectal cancer. Dig Liver Dis. 2009, 41: 116-122.CrossRefPubMed Gao J, Knutsen A, Arbman G, Carstensen J, Franlund B, Sun XF: Clinical and biological significance of angiogenesis and lymphangiogenesis in colorectal cancer. Dig Liver Dis. 2009, 41: 116-122.CrossRefPubMed
40.
go back to reference Longatto-Filho A, Pinheiro C, Ferreira L, Scapulatempo C, Alves VA, Baltazar F, Schmitt F: Peritumoural, but not intratumoural, lymphatic vessel density and invasion correlate with colorectal carcinoma poor-outcome markers. Virchows Arch. 2008, 452: 133-138.CrossRefPubMed Longatto-Filho A, Pinheiro C, Ferreira L, Scapulatempo C, Alves VA, Baltazar F, Schmitt F: Peritumoural, but not intratumoural, lymphatic vessel density and invasion correlate with colorectal carcinoma poor-outcome markers. Virchows Arch. 2008, 452: 133-138.CrossRefPubMed
41.
go back to reference Matsumoto K, Nakayama Y, Inoue Y, Minagawa N, Katsuki T, Shibao K, Tsurudome Y, Hirata K, Nagata N, Itoh H: Lymphatic microvessel density is an independent prognostic factor in colorectal cancer. Dis Colon Rectum. 2007, 50: 308-314.CrossRefPubMed Matsumoto K, Nakayama Y, Inoue Y, Minagawa N, Katsuki T, Shibao K, Tsurudome Y, Hirata K, Nagata N, Itoh H: Lymphatic microvessel density is an independent prognostic factor in colorectal cancer. Dis Colon Rectum. 2007, 50: 308-314.CrossRefPubMed
Metadata
Title
Quantification of tumour budding, lymphatic vessel density and invasion through image analysis in colorectal cancer
Authors
Peter D Caie
Arran K Turnbull
Susan M Farrington
Anca Oniscu
David J Harrison
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2014
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-12-156

Other articles of this Issue 1/2014

Journal of Translational Medicine 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine